U.S. Markets closed

BioTelemetry, Inc. (BEAT)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
32.00+0.35 (+1.11%)
At close: 4:00PM EDT
People also watch

BioTelemetry, Inc.

1000 Cedar Hollow Road
Suite 102
Malvern, PA 19355
United States

IndustryMedical Laboratories & Research
Full Time Employees1,087

Key Executives

Mr. Joseph H. CapperChief Exec. Officer, Pres and Director1.13MN/A53
Mrs. Heather C. Getz CPAChief Financial Officer and Exec. VP573.36kN/A42
Mr. Peter F. FerolaSr. VP of Corp. Devel., Gen. Counsel & Sec.494.5k268.62k48
Mr. Fred Broadway IIISr. VP of Sales and Marketing457.47kN/A47
Dr. Peter R. Kowey M.D., FACC, FACP, FACCP, FCPMedical Director and Chairman of Medical Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. It offers Mobile Cardiac Outpatient Telemetry and External Cardiac Ambulatory Telemetry services, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter and extended-wear Holter monitors to cardiologists and electrophysiologists. The Research Services segment provides cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, and expert reporting and statistical analysis. This segment also offers services in the cardiovascular, oncology, musculoskeletal, and neurologic therapeutic areas; and support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Technology segment focuses on the manufacture, engineering, and development of non-invasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors. BioTelemetry, Inc. is headquartered in Malvern, Pennsylvania.

Corporate Governance

BioTelemetry, Inc.’s ISS Governance QualityScore as of September 1, 2017 is 2. The pillar scores are Audit: 2; Board: 2; Shareholder Rights: 3; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.